Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 4 results:
Author Title Type [ Year(Asc)]
Filters: Author is Pollak, M.  [Clear All Filters]
2017
J. W. Wu, Azoulay, L., Majdan, A., Boivin, J. F., Pollak, M., and Suissa, S., “Long-Term Use of Long-Acting Insulin Analogs and Breast Cancer Incidence in Women With Type 2 Diabetes”, J Clin Oncol, vol. 35, pp. 3647-3653, 2017.
2015
L. Azoulay, Eberg, M., Benayoun, S., and Pollak, M., “5alpha-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer”, JAMA Oncol, vol. 1, pp. 314-20, 2015.
2011
S. Suissa, Azoulay, L., Dell'Aniello, S., Evans, M., Vora, J., and Pollak, M., “Long-term effects of insulin glargine on the risk of breast cancer”, Diabetologia, vol. 54, pp. 2254-62, 2011.
L. Azoulay, Dell'Aniello, S., Gagnon, B., Pollak, M., and Suissa, S., “Metformin and the incidence of prostate cancer in patients with type 2 diabetes”, Cancer Epidemiol Biomarkers Prev, vol. 20, pp. 337-44, 2011.
[Page last reviewed 6 April 2021]